Literature DB >> 12605702

Transient elevation of interleukin-16 levels at the initial stage of meningitis in children.

T Suzuki1, A Ishiguro, T Shimbo.   

Abstract

IL-16 is an immunomodulatory cytokine that is characterized by chemotactic activity and stimulation of proinflammatory cytokine expression in monocytic cells. We studied IL-16 using ELISA in children with meningitis. When meningeal symptoms existed, IL-16 levels were high in the cerebrospinal fluid (CSF) of both bacterial (939 +/- 877 ng/l, n = 20) and aseptic (341 +/- 371 ng/l, n = 23) meningitis. The values in the CSF were significantly higher than those in non-meningitis controls (29 +/- 8 ng/l, n = 22, P < 0.0001). After meningeal symptoms disappeared, IL-16 levels in bacterial (191 +/- 149 ng/l, n = 10, P = 0.0042) and aseptic (159 +/- 188 ng/l, n = 13, P = 0.0118) meningitis were lower than those during the symptomatic stage. IL-16 levels were the highest before day 5 of the illness and then gradually fell. Significant correlations were found between IL-16 levels and both G-CSF levels (r = 0.783, n = 11, p = 0.0029) and IL-6 levels (r = 0.818, n = 12, P = 0.0005) in the CSF of bacterial and aseptic meningitis. IL-16 levels in all CSF samples from non-meningitis controls were lower than those in serum. In contrast, IL-16 levels in the CSF in six of 16 samples from bacterial meningitis and two of 18 samples from aseptic meningitis were higher than those in serum. Serum levels of IL-16 did not fluctuate throughout the course of meningitis. These data indicate that IL-16 levels rise transiently in CSF at the initial stage of meningitis. We speculate that IL-16 may promote inflammatory responses during meningitis in concert with other proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605702      PMCID: PMC1808653          DOI: 10.1046/j.1365-2249.2003.02078.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells.

Authors:  P Zhou; K Devadas; D Tewari; A Jegorow; A L Notkins
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

2.  A role for IL-16 in the cross-talk between dendritic cells and T cells.

Authors:  A Kaser; S Dunzendorfer; F A Offner; T Ryan; A Schwabegger; W W Cruikshank; C J Wiedermann; H Tilg
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

3.  B lymphocyte-derived IL-16 attracts dendritic cells and Th cells.

Authors:  A Kaser; S Dunzendorfer; F A Offner; O Ludwiczek; B Enrich; R O Koch; W W Cruikshank; C J Wiedermann; H Tilg
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

4.  Cutting edge: CD4 is not required for the functional activity of IL-16.

Authors:  N L Mathy; N Bannert; S G Norley; R Kurth
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation.

Authors:  J Pirhonen; T Sareneva; I Julkunen; S Matikainen
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

Review 6.  Interleukin-16.

Authors:  W W Cruikshank; H Kornfeld; D M Center
Journal:  J Leukoc Biol       Date:  2000-06       Impact factor: 4.962

7.  Two subsets of dendritic cells are present in human cerebrospinal fluid.

Authors:  M Pashenkov; Y M Huang; V Kostulas; M Haglund; M Söderström; H Link
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

8.  Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells.

Authors:  M J Truong; E C Darcissac; E Hermann; J Dewulf; A Capron; G M Bahr
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism.

Authors:  D Sciaky; W Brazer; D M Center; W W Cruikshank; T J Smith
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels.

Authors:  A Ishiguro; T Nakahata; K Matsubara; Y Hayashi; T Kato; Y Suzuki; T Shimbo
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

View more
  1 in total

Review 1.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.